论文部分内容阅读
我们对96例恶性肿瘤病人的T3、T4和TSH进行了测定,现将结果报告如下。 对象和方法 一、对象:正常对照组59人,系门诊健康体检者。恶性肿瘤病人96例,均经CT、手术、病理确珍的住院患者,且无甲状腺疾病、近期内未服用影响甲状腺功能的药物,其中食道癌24人,肝癌25人,胃癌16人,卵巢癌11人,肝癌20人。 二、方法:被检者清晨空腹抽血3ml分离血清进行测定,T3、T4和TSH RIA kit由中国同位素公司北方所提供。仪器采用西安二六二厂生产的FJ-2008型自动γ免疫计数器,全部数据均有微机处理,操作按说明书。
We measured T3, T4, and TSH in 96 patients with malignant tumors. The results are reported below. Subjects and Methods I. Object: 59 normal control subjects, who were examined in the outpatient department. Ninety-six patients with malignant tumors were hospitalized with CT, surgery, and pathology. They had no thyroid disease and had not taken drugs that affect thyroid function in the near future. Among them, 24 were esophageal cancer, 25 were liver cancer, 16 were gastric cancer, and ovarian cancer. 11 people, liver cancer 20 people. 2. Methods: Subjects were fasted with 3 ml of blood serum for determination in the morning, and T3, T4 and TSH RIA kits were provided by China Isotope Corporation North. The instrument uses the FJ-2008 automatic gamma immunization counter produced by Xi’an 262 Factory. All data are processed by microcomputer and the operation is in accordance with the instructions.